Sanders Machelle

SEC CIK: 0001718020

SEC filings (opens in a new tab)

In the past year, 2 open-market sale filings worth $243.2K and no purchases.

Current role at each company

FTRE Fortrea Holdings Inc.Directoras of Aug 5, 2026
BCRX Biocryst Pharmaceuticals IncDirectoras of Jun 15, 2026
NOVN NVN Liquidation, Inc.Directoras of Jun 27, 2023
Radius Health, Inc.Directoras of Aug 15, 2022

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $243.2K; 2 filings
Net: −$243.2K; Bought minus sold
Companies: 2; With open-market trades

Trades

Every Form 4 that lists Sanders Machelle as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

FTRE Fortrea Holdings Inc.

Director1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Aug 5, 2026 (view filing)4:04 PM ET	Aug 3	2 days	Sanders MachelleDirector	SSale	−9.70K	$18.01	−$174.7K	−21.0%36.4K after

BCRX Biocryst Pharmaceuticals Inc

Director3 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Nov 17, 2025 (view filing)	Nov 13	4 days	Sanders MachelleDirector	SSale	−9.60K	$7.14	−$68.5K	−23.9%30.6K after	10b5-1
Jun 17, 2024 (view filing)	Jun 17	Same day	Sanders MachelleDirector	SSale	−4.69K	$6.00	−$28.1K	−14.5%27.7K after
Jun 15, 2023 (view filing)	Jun 15	Same day	Sanders MachelleDirector	SSale	−4.00K	$7.98	−$31.9K	−13.5%25.6K after

NOVN NVN Liquidation, Inc.